Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in mice
Brendon J. Hanson
,
Adrianus C.M. Boon
, Angeline P.C. Lim
, Ashley Webb
, Eng Eong Ooi
, Richard J. Webby
Division of Infectious Diseases
Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
Institute of Clinical and Translational Sciences (ICTS)
COVID-19 Researchers
Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
DBBS - Immunology
DBBS - Molecular Microbiology and Microbial Pathogenesis
Research output
:
Contribution to journal
›
Article
›
peer-review
113
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in mice'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Monoclonal Antibody
100%
Influenza A
100%
H5 Hemagglutinin
100%
Immunoprophylaxis
100%
Vietnam
75%
Containment
75%
Humanized
50%
Lethal Challenge
50%
H5N1 Virus
50%
C57BL
25%
Virus
25%
High Dose
25%
Public Health Risk
25%
Weight Loss
25%
Avian Influenza
25%
Neutralizing Monoclonal Antibody
25%
H5N1
25%
Post-infection
25%
Complete Protection
25%
Highly Pathogenic
25%
Pandemic Influenza Virus
25%
Passive Immunity
25%
Prophylactic Efficacy
25%
Hong Kong
25%
Future Pandemics
25%
Antibodies Neutralizing
25%
Antiviral Drug Resistance
25%
Immunology and Microbiology
Monoclonal Antibody
100%
Hemagglutinin
100%
Influenza
100%
Influenza A Virus (H5N1)
80%
Virus
60%
Infection
40%
C57BL 6 Mouse
20%
Drug Megadose
20%
Antiviral Resistance
20%
Aves
20%